Comparison of 3 body size descriptors in critically ill obese children and adolescents: implications for medication

Emma L Ross1, Jennifer Jorgensen1, Peter E DeWitt2

  • 1Department of Clinical Pharmacy, Children's Hospital Colorado, Aurora, Colorado.

Insights

Medication dosing in obese children requires accurate weight estimation. The Body Mass Index (BMI) method is the most feasible for routine pediatric intensive care unit use, showing good agreement below 50 kg.

Area of Science:

  • Pediatric critical care medicine
  • Clinical pharmacology
  • Biostatistics

Background:

  • Accurate weight determination is crucial for safe and effective medication dosing in pediatric patients, particularly those who are obese.
  • Existing methods for estimating weight in obese children, such as lean body mass estimations and ideal body weight calculations, vary in complexity and feasibility.

Purpose of the Study:

  • To compare three distinct methods for weight determination in medication dose calculations for obese children.
  • To evaluate the feasibility of these methods for routine clinical application in a pediatric intensive care unit setting.

Main Methods:

  • A patient safety and quality improvement study involving 176 obese and severely obese children (2-19 years) admitted to a pediatric intensive care unit.
  • Comparison of lean body mass estimations (Peters and Foster methods) against ideal body weight estimates (BMI method).
  • Statistical analysis included absolute differences, intraclass correlation (ICC), and Bland-Altman plots to assess agreement.

Main Results:

  • All three methods demonstrated strong correlation (mean ICC = 0.968) and acceptable agreement in children weighing less than 50 kg.
  • Systematic biases and increased variance were observed in children weighing above 50 kg, with sex influencing agreement.
  • The Peters method yielded higher weight estimates compared to the Foster or BMI methods.

Conclusions:

  • While all methods show good correlation, agreement varies with weight and sex, particularly above 50 kg.
  • The Body Mass Index (BMI) method is the least complex and most feasible for routine medication dosing calculations in obese pediatric patients.
  • Further refinement of weight estimation methods may be needed for children exceeding 50 kg to minimize systematic biases.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
364
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
437
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
547
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K